Impact of Ultra-processed Foods on Cardiometabolic Risk Factors

NCT ID: NCT06538831

Last Updated: 2024-10-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-25

Study Completion Date

2028-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to examine in a 2x2 factorial RCT what feature(s) of ultra-processed foods (UPFs) contribute to cardiometabolic risk in men and women. The project's hypotheses are :

1. that the nutrient composition of UPFs (high SFA, free sugar and sodium) per se has deleterious impacts on cardiometabolic risk factors;
2. that the industrial techniques and processes of UPFs per se do not.

Participants will be randomly assigned to one of 4 groups consistent with the 2x2 factorial design of the study: 1- the nutrient composition of foods (low vs. high in SFA, free sugar and sodium) and 2- the degree of industrial techniques and food processing (little to no vs.important amounts of UPFs). All foods will be provided to participants under isocaloric conditions during the 6-week dietary intervention. Participants will have to consume one of the 4 experimental diets for 6 weeks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a parallel group 2x2 factorial randomized controlled trial, in which diet is fully controlled. A total of 120 men and women covering a broad range of adiposity and cardiometabolic risk factors will be randomly assigned to one of four 6-week experimental diets:

1. A diet low in saturated fatty acids (SFAs), free sugar and sodium, with low ultra-processed foods (UPFs)
2. A diet rich in SFAs, free sugar and sodium, with low UPFs;
3. A diet low in SFAs, free sugar and sodium, with high levels of UPFs;
4. A diet rich in SFAs, free sugar and sodium, with high levels of UPFs.

All foods in this full-feeding trial will be managed or prepared by food technicians at the Clinical Investigation Unit of our research center. A cyclic seven-day menu plan will be developed with similar foods across the four diets. Classifications of the degree of food processing will be made using NOVA classification. NOVA identifies four categories of foods based on the degree of food processing: 1- Unprocessed or minimally processed foods, 2- Processed Culinary Ingredients, 3- Processed Food and 4- Ultra-processed foods (UPFs). The two diets high in UPFs will predominantly feature commercially-bought foods classified as NOVA-4, while the two diets low in UPFs diets will predominantly include foods prepared in our metabolic kitchen (NOVA 1 to 3). Diets will be provided under isocaloric conditions to maintain body weight constant. The breakfast meal will represent approximately 30% of the daily energy intake in each diet, whereas the lunch and dinner meals each will provide about 35% of daily energy intake. Participants will have to come to the research center 3 to 5 times a week during the 6-week intervention to collect their meals and be weighed. Primary and secondary outcomes will be measured at the beginning and at the end of the 6-wk diet intervention.

The specifics objectives of this 2x2 factorial RCT are:

Obj 1: To assess the impact of the nutrient composition of UPFs on cardiometabolic risk, independent of variations in industrial techniques and processes (factor 1).

Obj 2: To assess the impact of industrial techniques and processes of UPFs on cardiometabolic risk, independent of variations in nutrient composition (factor 2).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiometabolic Risk

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Parallel group 2x2 factorial randomized controlled trial in fully controlled feeding conditions
Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Diet N-P-

Group Type EXPERIMENTAL

Diet N-P-

Intervention Type OTHER

Low in saturated fatty acids (SFAs), free sugar and sodium; Low in ultra-processed foods (UPFs)

Diet N+P-

Group Type EXPERIMENTAL

Diet N+P-

Intervention Type OTHER

Rich in SFAs, free sugar and sodium; Low in UPFs

Diet N-P+

Group Type EXPERIMENTAL

Diet N-P+

Intervention Type OTHER

Low in SFAs, free sugar and sodium; High in UPFs

Diet N+P+

Group Type EXPERIMENTAL

Diet N+P+

Intervention Type OTHER

Rich in SFAs, free sugar and sodium; High in UPFs

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Diet N-P-

Low in saturated fatty acids (SFAs), free sugar and sodium; Low in ultra-processed foods (UPFs)

Intervention Type OTHER

Diet N+P-

Rich in SFAs, free sugar and sodium; Low in UPFs

Intervention Type OTHER

Diet N-P+

Low in SFAs, free sugar and sodium; High in UPFs

Intervention Type OTHER

Diet N+P+

Rich in SFAs, free sugar and sodium; High in UPFs

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Body mass index (BMI):18 to 35 kg/m2
* Stable weight over the last 3 months (variation of less than 5 kg)
* LDL-cholesterol \< 5.0 mmol/L
* HbA1c \< 6.5%
* Office blood pressure \<150/90 mmHg
* Non-smokers or smokers of less than 10 cigarettes a day

Exclusion Criteria

* Pregnant or breast-feeding women
* Alcohol consumption of more than 7 drinks per week
* Women: contraceptives for less than 3 months or hormone therapy for less than 6 months
* Medication to treat hypercholesterolemia, diabetes or hypertension
* Diagnosis of cardiovascular disease, diabetes, hypertension, cancer
* Food allergies or aversions to any of the foods on the experimental menus
* Being on a diet or following a special diet
* Daytime MAPA blood pressure \>150/90
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

Sponsor Role collaborator

Laval University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Benoit Lamarche

Study director

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Benoît Lamarche, PhD

Role: PRINCIPAL_INVESTIGATOR

Laval University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Nutrition, santé et société (NUTRISS), INAF, Université Laval

Québec, Quebec, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Benoît Lamarche, PhD

Role: CONTACT

418-656-3527

Iris Gigleux, MSc

Role: CONTACT

418-656-2131 ext. 405087

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Benoît Lamarche, PhD

Role: primary

418-656-3527

Iris Gigleux, MSc

Role: backup

418-656-2131 ext. 405087

Benoît Lamarche, PhD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NUTRISS-NOVA-2024-219

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.